Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Net Cash Flow (2025 - 2026)

Updated

Seaport Therapeutics' Net Cash Flow came in at -$2.67 million for Q3 2026, compared with -$672,000 a year earlier.

Analysis

Seaport Therapeutics (SPTX) Net Cash Flow (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Seaport Therapeutics reported Net Cash Flow of $15.65 million; for FY2025, it came in at -$263.06 million.

  • Going back by year, Net Cash Flow was $309.55 million in FY2024.
  • The Q3 2026 figure represents the lowest quarterly Net Cash Flow since Q2 2025.
  • Business Quant data shows SPTX's Net Cash Flow at $11.29 million (Q2 2026), $6.9 million (Q1 2026) and $136,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -3.52 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.21 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.41 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 3.26 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 843.00 Mn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - -2.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.67 Mn
Jun 30, 2026 11.29 Mn
Mar 31, 2026 6.90 Mn
Dec 31, 2025 136,000.00
Sep 30, 2025 -672,000.00
Jun 30, 2025 -16.77 Mn
Mar 31, 2025 -245.76 Mn
API Access

Seaport Therapeutics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SPTX&period=max&api_key=YOUR_API_KEY